INOVIO PHARMACEUTICALS, INC.

INO

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001770390-26-000003
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Common Stock Option

Action

Grant

Date

2026-03-04

Code

A

Net shares

+26,840.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

26,840.0

Transaction 2

Security

Restricted Stock Unit

Action

Grant

Date

2026-03-04

Code

A

Net shares

+21,560.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

21,560.0

Filing's footnotes

1. The vesting schedule for the 26,840 options granted on March 4, 2026 was as follows: 8,947 shares will vest on February 26, 2027; 8,947 shares will vest on February 26, 2028; 8,946 shares will vest on February 26, 2029.

2. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.